Berg, M. H., Rincón, S. V. d., & Miller, W. H. (2022). Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: From monoclonal antibodies to kinase inhibition.
Lua i Stíl Chicago (17ú heag.)Berg, Meagan‐Helen Henderson, Sonia V. del Rincón, agus Wilson H. Miller. Potential Therapies for Immune-related Adverse Events Associated with Immune Checkpoint Inhibition: From Monoclonal Antibodies to Kinase Inhibition. 2022.
Lua MLA (9ú heag.)Berg, Meagan‐Helen Henderson, et al. Potential Therapies for Immune-related Adverse Events Associated with Immune Checkpoint Inhibition: From Monoclonal Antibodies to Kinase Inhibition. 2022.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.